The continued appeal of global food businesses to strategic and financial buyers provides an element of certainty in an uncertain economic climate.

I can foresee the first rumours breaking imminently

It’s no surprise to see that pharmaceutical conglomerates around the world have looked in recent times to India for their next big deals

Russia appears to be the only BRIC market Publicis is being slow to enter.

Given that he is in deal-making mode perhaps he might turn his attention to the issues still facing many small to mid-market deal makers in the UK.